Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

373 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cannabinoids and Psychosis.
D'Souza DC, Radhakrishnan R, Sherif M, Cortes-Briones J, Cahill J, Gupta S, Skosnik PD, Ranganathan M. D'Souza DC, et al. Among authors: sherif m. Curr Pharm Des. 2016;22(42):6380-6391. doi: 10.2174/1381612822666160826105628. Curr Pharm Des. 2016. PMID: 27568729 Review.
Human Laboratory Studies on Cannabinoids and Psychosis.
Sherif M, Radhakrishnan R, D'Souza DC, Ranganathan M. Sherif M, et al. Biol Psychiatry. 2016 Apr 1;79(7):526-38. doi: 10.1016/j.biopsych.2016.01.011. Epub 2016 Feb 2. Biol Psychiatry. 2016. PMID: 26970363 Review.
Cannabis-associated psychosis: Neural substrate and clinical impact.
Murray RM, Englund A, Abi-Dargham A, Lewis DA, Di Forti M, Davies C, Sherif M, McGuire P, D'Souza DC. Murray RM, et al. Among authors: sherif m. Neuropharmacology. 2017 Sep 15;124:89-104. doi: 10.1016/j.neuropharm.2017.06.018. Epub 2017 Jun 17. Neuropharmacology. 2017. PMID: 28634109 Review.
The Psychiatric Consequences of Cannabinoids.
De Aquino JP, Sherif M, Radhakrishnan R, Cahill JD, Ranganathan M, D'Souza DC. De Aquino JP, et al. Among authors: sherif m. Clin Ther. 2018 Sep;40(9):1448-1456. doi: 10.1016/j.clinthera.2018.03.013. Epub 2018 Apr 17. Clin Ther. 2018. PMID: 29678279 Review.
Efficacy and safety of a fatty acid amide hydrolase inhibitor (PF-04457845) in the treatment of cannabis withdrawal and dependence in men: a double-blind, placebo-controlled, parallel group, phase 2a single-site randomised controlled trial.
D'Souza DC, Cortes-Briones J, Creatura G, Bluez G, Thurnauer H, Deaso E, Bielen K, Surti T, Radhakrishnan R, Gupta A, Gupta S, Cahill J, Sherif MA, Makriyannis A, Morgan PT, Ranganathan M, Skosnik PD. D'Souza DC, et al. Among authors: sherif ma. Lancet Psychiatry. 2019 Jan;6(1):35-45. doi: 10.1016/S2215-0366(18)30427-9. Epub 2018 Dec 6. Lancet Psychiatry. 2019. PMID: 30528676 Clinical Trial.
Modulation of the antidepressant effects of ketamine by the mTORC1 inhibitor rapamycin.
Abdallah CG, Averill LA, Gueorguieva R, Goktas S, Purohit P, Ranganathan M, Sherif M, Ahn KH, D'Souza DC, Formica R, Southwick SM, Duman RS, Sanacora G, Krystal JH. Abdallah CG, et al. Among authors: sherif m. Neuropsychopharmacology. 2020 May;45(6):990-997. doi: 10.1038/s41386-020-0644-9. Epub 2020 Feb 24. Neuropsychopharmacology. 2020. PMID: 32092760 Free PMC article. Clinical Trial.
Dose-related effects of ketamine for antidepressant-resistant symptoms of posttraumatic stress disorder in veterans and active duty military: a double-blind, randomized, placebo-controlled multi-center clinical trial.
Abdallah CG, Roache JD, Gueorguieva R, Averill LA, Young-McCaughan S, Shiroma PR, Purohit P, Brundige A, Murff W, Ahn KH, Sherif MA, Baltutis EJ, Ranganathan M, D'Souza D, Martini B, Southwick SM, Petrakis IL, Burson RR, Guthmiller KB, López-Roca AL, Lautenschlager KA, McCallin JP 3rd, Hoch MB, Timchenko A, Souza SE, Bryant CE, Mintz J, Litz BT, Williamson DE, Keane TM, Peterson AL, Krystal JH. Abdallah CG, et al. Among authors: sherif ma. Neuropsychopharmacology. 2022 Jul;47(8):1574-1581. doi: 10.1038/s41386-022-01266-9. Epub 2022 Jan 19. Neuropsychopharmacology. 2022. PMID: 35046508 Free PMC article. Clinical Trial.
mTORC1 inhibitor effects on rapid ketamine-induced reductions in suicidal ideation in patients with treatment-resistant depression.
Averill LA, Averill CL, Gueorguieva R, Fouda S, Sherif M, Ahn KH, Ranganathan M, D'Souza DC, Southwick SM, Sanacora G, Duman RS, Krystal JH, Abdallah CG. Averill LA, et al. Among authors: sherif m. J Affect Disord. 2022 Apr 15;303:91-97. doi: 10.1016/j.jad.2022.01.104. Epub 2022 Jan 29. J Affect Disord. 2022. PMID: 35101523 Clinical Trial.
373 results